Guided Therapeutics (GTHP) Receivables - Other (2011 - 2022)

Guided Therapeutics has disclosed Receivables - Other across 6 years of filings, most recently posting $82984.0 for Q4 2022.

• In Q4 2022, Receivables - Other changed N/A year-over-year to $82984.0; the TTM figure through Dec 2022 stood at $82984.0 (changed N/A YoY), while the FY2022 annual figure was $82984.0, changed N/A from the prior year.
• Receivables - Other came in at $82984.0 for Q4 2022 at Guided Therapeutics, up from $43057.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $350.0 million in Q2 2021 to a low of $24785.0 in Q2 2022.
• Average Receivables - Other over 5 years is $39.5 million, with a median of $130000.0 recorded in 2022.
• Year-over-year, Receivables - Other soared 3280.0% in 2021 and plunged 99.99% in 2022.
• Over 5 years, Receivables - Other stood at $661000.0 in 2018, then retreated by 3.93% to $635000.0 in 2019, then tumbled by 84.25% to $100000.0 in 2020, then soared by 349900.0% to $350.0 million in 2021, then plunged by 99.98% to $82984.0 in 2022.
• Per Business Quant data, the three most recent Receivables - Other figures were $82984.0 in Q4 2022, $43057.0 in Q3 2022, and $24785.0 in Q2 2022.